Partnering to Unlock Hope for the Future of Cancer Care: Live from SXSW 2024

·42 min·2 clips

Harlan Levine says narrow networks can block patients with rare cancers from reaching the right expertise.

1. The Real Chemistry Podcast episode at SXSW 2024 centers on “Partnering to Unlock Hope for the Future of Cancer Care.” 2. Aaron Strout hosts Dr. Harlan Levine of City of Hope, Dr. Karen Knudson of the American Cancer Society, and Dr. Cliff Hottis of ASCO, and each leader brings a different part of the cancer-care system. 3. The episode asks what partnership can do for cancer care when access, expertise, and prevention are all changing at once. 4. Harlan Levine says City of Hope is a National Cancer Institute designated comprehensive cancer center that treats about 121,000 people with cancer and now operates across five major counties in four states. 5. Cliff Hottis says ASCO is multidisciplinary by design and includes medical oncology, surgical oncology, radiation oncology, pathologists, and psychiatrists. 6. Karen Knudson says the American Cancer Society represents the 2 million people in America who will hear a cancer diagnosis this year and the 600,000 who will die of the disease. 7. Knudson says ACS works through research, advocacy, and patient support, including transportation, lodging, patient navigation, and patient education. 8. Levine says City of Hope moved away from the “ivory tower” model about 15 years ago and now works with communities, policy, health plans, and employers. 9. The panel argues that cancer patients have to navigate a “deeply Byzantine path” that can include surgery, medical oncology, genetic testing, and possible clinical trials. 10. Knudson says 16% of her Jefferson Health oncology patients missed care in a given year because they had no ride. 11. Knudson says the U.S. has cut overall cancer mortality by 33% since 1991, and she attributes much of that to prevention and early detection. 12. She cites a 65% reduction in cervical cancer incidence among women ages 20 to 24, which she links to HPV vaccination. 13. Levine says Australia has set a goal of eliminating HPV-caused malignancy, and Knudson points to Puerto Rico’s 90% adolescent HPV vaccination uptake. 14. Levine notes hepatitis B vaccination as another cancer-prevention tool and says it lowers risk for hepatocellular carcinoma. 15. Levine argues that narrow insurance networks can block patients with rare cancers from reaching the right expert, especially now that precision medicine has created hundreds of cancer subtypes. 16. He says a patient bill of rights should include access to the right expertise, culturally sensitive care, navigation, and research trials, and he says California turned that idea into a Medicaid-linked mandate. 17. Hottis says the Affordable Care Act required commercial insurers and Medicare to cover routine costs for patients enrolled in clinical trials, which helped reduce barriers at Memorial Sloan Kettering. 18. The episode keeps a practical, policy-focused interview style, and the speakers often answer with numbers, examples, and direct recommendations. 19. People working in oncology, health policy, patient advocacy, or employer-sponsored benefits will get the most from it. 20. Listeners looking for a personal-story episode rather than policy and systems discussion may skip it.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from The Real Chemistry Podcast